-
Epalrestat: Reframing Polyol Pathway Translation
2026-08-21
A translational framework for using Epalrestat to connect polyol pathway inhibition, oxidative stress research, diabetic neuropathy research, neuroprotection, and emerging questions in fructose-driven cancer metabolism.
-
5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
2026-08-20
This DMSO-soluble α2-adrenergic receptor agonist supports mechanistic studies of receptor signaling, immune rejection modulation, and post-surgical osteosarcoma recurrence models. The article translates reference findings into practical cell, hydrogel, and immune-assay workflows with troubleshooting guidance for solvent control, stability, and interpretation.
-
Itraconazole in Candida Biofilm Research
2026-08-20
Itraconazole is a triazole antifungal agent that can connect direct fungal growth assays with Candida biofilm, CYP3A4, and host-signaling studies. This workflow shows how to control solubility, separate antifungal activity from pathway effects, and translate PP2A–autophagy findings into more informative experiments.
-
Antipyrine B1886: CNS Workflow Benchmark
2026-08-19
Antipyrine, also called 1,5-dimethyl-2-phenylpyrazol-3-one, is a research-grade analgesic and antipyretic compound with reported high solubility and 99.98% purity. It can support pharmacokinetic studies and drug metabolism research, but its product specifications do not independently establish blood-brain barrier permeability.
-
Pravastatin Sodium: A Transporter-Aware Assay Strategy
2026-08-19
Pravastatin sodium is a powerful HMG-CoA reductase inhibitor, but its cellular effects depend on uptake, viability, and assay context. This guide combines cholesterol biology with hepatocyte transporter findings to improve experimental design and interpretation.
-
Firefly Luciferase mRNA: LNP Assay Guide
2026-08-18
Use Firefly Luciferase mRNA (ARCA, 5-moUTP) as a sensitive control for transfection, translation, cell viability workflows, and in vivo delivery studies. This guide connects practical reporter assay design with freeze-thaw LNP findings, helping researchers distinguish mRNA integrity problems from nanoparticle delivery failures.
-
Caspofungin: Reading Glucan-Targeting Assays
2026-08-18
Caspofungin is a lipopeptide antifungal drug whose value extends beyond potent glucan synthase inhibition. This article explains how to interpret susceptibility, persistence, resistance, and in vivo endpoints when evaluating Candida therapeutics.
-
Kir7.1 Glycosylation, GPCRs, and Channel Activity
2026-08-17
Carrington and colleagues showed that GPCRs regulate Kir7.1 through differential control of channel glycosylation rather than through the canonical GIRK mechanism. Their experiments connect reduced complex glycosylation with impaired Kir7.1 activity while preserving cell-surface abundance, providing a mechanistic framework for interpreting receptor–channel regulation and disease-associated Kir7.1 variants.
-
Affinity-Purified Goat Anti-Mouse IgG (H+L) Guide
2026-08-17
This practical guide shows how to use an HRP-conjugated goat anti-mouse reagent across Western blotting, ELISA, IHC, and ICC while controlling background and preserving signal. It also translates a bladder cancer mRNA–LNP study into concrete antibody-validation choices for measuring p21 restoration and tissue response.
-
Paroxetine Mesylate: A Translational Playbook
2026-08-16
A mechanism-first strategy for using Paroxetine Mesylate as both a serotonin transporter probe and a multi-target translational research tool across neuropharmacology, pharmacokinetics, and oncology.
-
Sulfaphenazole: From CYP2C9 Probe to Tissue Repair
2026-08-15
Sulfaphenazole is more than a conventional CYP2C9 inhibitor: it offers translational researchers a mechanistic bridge between cytochrome P450 activity, oxidative stress, vascular dysfunction, and tissue repair. This article examines the evidence, practical assay strategy, competitive landscape, and limits of moving from enzyme inhibition to preclinical wound and infection models.
-
Fructose Metabolism as a Cancer Therapy Target
2026-08-14
The 2025 Cancer Letters review by Zhao and colleagues positions fructose metabolism as a flexible nutrient and signaling network that supports aggressive tumor behavior, particularly under nutrient stress. Its synthesis of cancer epidemiology, transporter and enzyme biology, and therapeutic opportunities highlights polyol pathway enzymes such as AKR1B1 as potential intervention points while emphasizing that most evidence remains mechanistic or preclinical.
-
Oteseconazole: A Mechanism-First Assay Guide
2026-08-14
Oteseconazole (VT-1161) is a selective tetrazole CYP51 inhibitor with strong activity against diverse Candida species. This mechanism-first guide explains how to interpret its potency, select assay endpoints, and avoid overextending in vitro findings into clinical conclusions.
-
Açaí Extracts in Human Hepatocytes: Key Findings
2026-08-13
Raichura and colleagues evaluated how solvent-specific açaí extracts affect human hepatocyte viability, drug-metabolizing enzymes, and transporters. The study found extract-dependent cytotoxicity without significant induction of the tested CYP450 enzymes or transporters, providing a useful framework for assessing botanical–drug interaction risk.
-
Sulfamonomethoxine: From Mechanism to Stewardship
2026-08-13
Sulfamonomethoxine, or SMM, is more than a veterinary sulfonamide: it is a practical model for connecting dihydropteroate synthase biology, translational assay design, antimicrobial resistance, and environmental stewardship. This article presents a mechanism-led framework for evaluating SMM in bacterial, aquaculture, and ecotoxicology workflows while clarifying what the evidence does—and does not—support.